Royce & Associates’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Royce & Associates’s Portfolio FLXN Stock Details FLXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-451,037	Closed	-$3.71M	–	1039
2021 Q2	$3.71M	Sell	451,037 -106,400	-19%	-$905K	0.03%	661
2021 Q1	$4.99M	Sell	557,437 -70,057	-11%	-$803K	0.03%	598
2020 Q4	$7.24M	Sell	627,494 -74,000	-11%	-$860K	0.06%	465
2020 Q3	$7.3M	Buy	701,494 +34,000	+5%	+$417K	0.08%	374
2020 Q2	$8.78M	Buy	667,494 +91,000	+16%	+$944K	0.1%	300
2020 Q1	$4.54M	Buy	576,494 +235,192	+69%	+$3.54M	0.06%	400
2019 Q4	$7.07M	Buy	341,302 +16,294	+5%	+$275K	0.06%	408
2019 Q3	$4.45M	Buy	325,008 +218,384	+205%	+$2.59M	0.04%	507
2019 Q2	$1.31M	Buy	106,624 +91,600	+610%	+$1.06M	0.01%	804
2019 Q1	$187K	Buy	+15,024	New	+$201K	﹤0.01%	997
2018 Q4	–	Sell	-44,795	Closed	-$838K	–	1222
2018 Q3	$838K	Hold	44,795	–	–	0.01%	945
2018 Q2	$1.16M	Hold	44,795	–	–	0.01%	916
2018 Q1	$1M	Hold	44,795	–	–	0.01%	967
2017 Q4	$1.12M	Sell	44,795 -5,205	-10%	-$127K	0.01%	956
2017 Q3	$1.21M	Hold	50,000	–	–	0.01%	915
2017 Q2	$1.01M	Hold	50,000	–	–	0.01%	974
2017 Q1	$1.35M	Buy	+50,000	New	+$1.02M	0.01%	935

Other funds holding FLXN

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Clearline Capital New York $1.29B AUM 38.13% 1-Year Est. Return

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return